Glycated Haemoglobin Testing Market Growth and Forecast 2025-2032 reflects the rapid advancements in diabetes diagnostics. Accurate monitoring of glycated haemoglobin levels is critical for therapeutic decision-making and improving patient outcomes globally. This analysis offers key market insights and strategic market research for stakeholders seeking robust business growth, while the market forecast indicates sustained momentum through 2032. Global Glycated Haemoglobin Testing Market A detailed market analysis underscores the competitive landscape of market companies and market players driving innovation, aligning with emerging industry trends in decentralized testing.
The glycated haemoglobin testing market is estimated to be valued at USD 260.0 Mn in 2025 and is expected to reach USD 469.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.
Market Size and Overview
This market report highlights robust industry size expansion driven by rising diabetes prevalence and shifting healthcare priorities. According to the Glycated Haemoglobin Testing Market report, this surge is supported by enhanced assay precision and increasing clinical adoption. Data indicate the industry share of emerging POC segments has climbed to 30% in 2025, reflecting shifting market segments toward decentralized testing. When evaluating market size and market report data, stakeholders noted that sustained R&D investments and favorable reimbursement policies are key success factors.Market Drivers- Rising Diabetes Prevalence:* Global diabetes cases increased by 9% in 2025 (IDF), creating significant market opportunities for advanced HbA1c tests.* 2024 NIH data indicate a 12% year-over-year test volume increase in North America.* Premium point-of-care devices accounted for 20% of Glycated Haemoglobin Testing Market share and contributed to a 15% uplift in Glycated Haemoglobin Testing Market revenue, illustrating key Glycated Haemoglobin Testing Market trends toward decentralization.
PEST Analysis-
Political:* 2024 EU Medical Device Regulation updates tightened approval pathways, elevating device quality standards but also presenting market challenges in compliance and registration timelines.- Economic:* 2025 global healthcare spending grew by 6%, fueling favorable investment dynamics and mitigating market restraints linked to cost concerns.- Social:* 2025 surveys show rising patient preference for rapid testing; 70% of clinics implemented POC HbA1c testing, expanding market scope at the point of care.- Technological:* 2024 introduction of AI-based assay calibration improved accuracy by 8%, accelerating adoption among labs and reshaping market dynamics.
Promotion and Marketing Initiative- Roche Diagnostics’ 2024 CME Workshops in Asia:* Conducted over 50 workshops to educate endocrinologists on HbA1c assay interpretation, resulting in a 10% rise in test orders.* Enhanced brand visibility and supported market growth strategies by fostering key opinion leader endorsements and driving market trends engagement.
Key Players- Abbott Laboratories- Roche Diagnostics- Siemens Healthineers- Tosoh Corporation- Bio-Rad Laboratories- Danaher (Beckman Coulter)- Becton Dickinson- EKF Diagnostics- Trividia Health- Nova Biomedical- ARKRAY- Quest Diagnostics- Beckman Coulter- DiaSys Diagnostic Systems- HUMAN Diagnostics
Recent Strategic Highlights:- Abbott Laboratories launched its next-generation POC HbA1c analyzer in 2025, boosting its market share by 8% in North America.- Roche Diagnostics partnered with a major hospital network in India in 2024, expanding service contracts and driving a 12% increase in test volumes.- Siemens Healthineers expanded its Malaysia production facility in 2025, reducing lead times by 20% and supporting overall market revenue growth.
FAQs 1. Who are the dominant players in the Glycated Haemoglobin Testing Market?Leading companies include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Tosoh Corporation and Bio-Rad Laboratories, each leveraging product innovation and strategic partnerships.2. What will be the size of the Glycated Haemoglobin Testing Market in the coming years?The Global Glycated Haemoglobin Testing Market is projected to grow from USD 260.0 Mn in 2025 to USD 469.2 Mn by 2032 at an 8.8% CAGR, reflecting strong market growth.3. Which end-user segment has the largest growth opportunity?Hospitals and diagnostic laboratories dominate market segments, with rapid adoption of POC analyzers in outpatient settings offering significant expansion potential.4. How will market trends in the Glycated Haemoglobin Testing Market evolve over the next five years?Trends point to increased decentralization via POC testing, integration of AI for assay accuracy, and digital health platforms driving remote monitoring and personalized care.5. What is the nature of the competitive landscape and challenges in the Glycated Haemoglobin Testing Market?The landscape is highly competitive, marked by regulatory hurdles, pricing pressures, and the need for continuous technological advancements to overcome market restraints.6. What go-to-market strategies are commonly adopted in the Glycated Haemoglobin Testing Market?Companies employ clinical workshops, digital marketing campaigns, strategic collaborations, and subscription-based service models to enhance adoption and sustain business growth.
Get this Report in Japanese Language: グリコヘモグロビン検査市場
Get this Report in Korean Language: 당화혈색소검사시장
Get more related Articles on: Advances in Hemophilia Treatment in the United States Over the Past Few Decades
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191__
The new report by Expert Market Research titled, ‘Global Glycated Haemoglobin Testing Market Report and Forecast 2021-2026’, gives in-depth analysis of the global glycated haemoglobin testing market, assessing the market based on its segments like product type, technology, end-use, and major regions.
The sample report shall be delivered to you within 24 hours.Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/glycated-haemoglobin-testing-market/requestsampleThe key highlights of the report include:Market Overview:Forecast CAGR (2021-2026): 9%Growing diabetic patients, increasing geriatric population, technical developments in diagnosing diabetes, growth in the home healthcare industry, and increased early detection R activities and successful disease management are the key factors contributing to the growth of the glycated haemoglobin testing market.
However, the market development is likely to be hampered by the existence of alternatives and high costs associated with glycated haemoglobin research.
In developing countries, an increase in the diabetic population and rising awareness of POC HbA1c testing are expected to fuel market growth soon.Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/glycated-haemoglobin-testing-marketIndustry Definition and Major SegmentsTo calculate the three-month average plasma glucose concentration, glycated haemoglobin is used.
It is a standardised test that demonstrates the amount of HbA1c, a specific type of glycated haemoglobin, in the blood of individuals during the past two to four months.
The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.Read More Reports:-Global Motion Sensor Market: https://www.expertmarketresearch.com/reports/motion-sensor-marketGlobal Moulded Pulp Packaging Market: https://www.expertmarketresearch.com/reports/molded-pulp-packaging-marketGlobal Mould Release Agents Market: https://www.expertmarketresearch.com/reports/mold-release-agents-marketGlobal Lung Stent Market: https://www.expertmarketresearch.com/reports/lung-stent-marketJapanese Encephalitis Vaccine Market: https://www.expertmarketresearch.com/reports/japanese-encephalitis-vaccine-marketGlobal Instrument Transformer Market: https://www.expertmarketresearch.com/reports/instrument-transformer-marketGlobal HPV Associated Disorders Market: https://www.expertmarketresearch.com/reports/hpv-associated-disorders-marketGlobal Hot Runner Market: https://www.expertmarketresearch.com/reports/hot-runner-marketGlobal Hormonal Contraceptive Market: https://www.expertmarketresearch.com/reports/hormonal-contraceptive-marketGlobal Homecare Ventilator Market: https://www.expertmarketresearch.com/reports/homecare-ventilator-marketNote 2: As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours.
